{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T13:59:03Z","timestamp":1774533543548,"version":"3.50.1"},"reference-count":72,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T00:00:00Z","timestamp":1770768000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T00:00:00Z","timestamp":1774483200000},"content-version":"vor","delay-in-days":43,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000050","name":"NHLBI","doi-asserted-by":"crossref","award":["U24HL135600"],"award-info":[{"award-number":["U24HL135600"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000050","name":"NHLBI","doi-asserted-by":"crossref","award":["1U24HL135881"],"award-info":[{"award-number":["1U24HL135881"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Syst Rev"],"DOI":"10.1186\/s13643-026-03077-1","type":"journal-article","created":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T23:22:29Z","timestamp":1770852149000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Burden and outcomes of cardiovascular and pulmonary complications in adolescents and adults with sickle cell disease: a systematic review and meta-analysis"],"prefix":"10.1186","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2409-4502","authenticated-orcid":false,"given":"Natasha Mupeta","family":"Kaweme","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sahar Mounir Nagib","family":"Buttress","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arthemon","family":"Nguweneza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cynthia","family":"Phiri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takudzwa Joylyn","family":"Mtisi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pauline Musukwa","family":"Sambo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gwendoline","family":"Kandawasvika","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hamakwa Muluti","family":"Mantina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patience","family":"Kuona","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catherine Mupela","family":"Chunda-Liyoka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,11]]},"reference":[{"issue":"38","key":"3077_CR1","doi-asserted-by":"publisher","first-page":"e35237","DOI":"10.1097\/MD.0000000000035237","volume":"102","author":"C Elendu","year":"2023","unstructured":"Elendu C, Amaechi DC, Alakwe-Ojimba CE, Elendu TC, Elendu RC, Ayabazu CP, et al. Understanding sickle cell disease: causes, symptoms, and treatment options. Medicine (Baltimore). 2023;102(38):e35237. https:\/\/doi.org\/10.1097\/MD.0000000000035237.","journal-title":"Medicine (Baltimore)"},{"key":"3077_CR2","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s12878-017-0079-7","volume":"17","author":"AM Andong","year":"2017","unstructured":"Andong AM, Ngouadjeu EDT, Bekolo CE, Verla VS, Nebongo D, Mboue-Djieka Y, et al. Chronic complications and quality of life of patients living with sickle cell disease and receiving care in three hospitals in Cameroon: a cross-sectional study. BMC Hematol. 2017;17:7. https:\/\/doi.org\/10.1186\/s12878-017-0079-7.","journal-title":"BMC Hematol"},{"key":"3077_CR3","doi-asserted-by":"crossref","unstructured":"Asnani MR, Reid ME, Ali SB, Lipps G, Williams-Green P. Quality of life in patients with sickle cell disease in Jamaica: rural-urban differences. Rural Remote Health. 2008;8(2):890. Epub 2008 Apr 11. PMID: 18410222.","DOI":"10.22605\/RRH890"},{"key":"3077_CR4","unstructured":"WHO | Regional Office for Africa. 2024. Sickle Cell Disease. Available from: https:\/\/www.afro.who.int\/health-topics\/sickle-cell-disease."},{"issue":"2","key":"3077_CR5","doi-asserted-by":"publisher","first-page":"e14699","DOI":"10.1371\/journal.pone.0014699","volume":"6","author":"J Makani","year":"2011","unstructured":"Makani J, Cox SE, Soka D, Komba AN, Oruo J, Mwamtemi H, et al. Mortality in sickle cell anemia in Africa: a prospective cohort study in Tanzania. PLoS ONE. 2011;6(2):e14699. https:\/\/doi.org\/10.1371\/journal.pone.0014699.","journal-title":"PLoS ONE"},{"issue":"2","key":"3077_CR6","doi-asserted-by":"publisher","first-page":"021103","DOI":"10.7189\/jogh.08.021103","volume":"8","author":"E Wastnedge","year":"2018","unstructured":"Wastnedge E, Waters D, Patel S, Morrison K, Goh MY, Adeloye D, et al. The global burden of sickle cell disease in children under five years of age: a systematic review and meta-analysis. J Glob Health. 2018;8(2):021103. https:\/\/doi.org\/10.7189\/jogh.08.021103.","journal-title":"J Glob Health"},{"issue":"6","key":"3077_CR7","doi-asserted-by":"publisher","first-page":"e20160348","DOI":"10.1542\/peds.2016-0348","volume":"137","author":"PT McGann","year":"2016","unstructured":"McGann PT. Time to invest in sickle cell anemia as a global health priority. Pediatrics. 2016;137(6):e20160348. https:\/\/doi.org\/10.1542\/peds.2016-0348.","journal-title":"Pediatrics"},{"key":"3077_CR8","unstructured":"Non communicable diseases. Available from: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/noncommunicable-diseases."},{"issue":"8","key":"3077_CR9","doi-asserted-by":"publisher","first-page":"e585","DOI":"10.1016\/S2352-3026(23)00118-7","volume":"10","author":"AM Thomson","year":"2023","unstructured":"Thomson AM, McHugh TA, Oron AP, Teply C, Lonberg N, VilchisTella V, et al. Global, regional, and national prevalence and mortality burden of sickle cell disease, 2000\u20132021: a systematic analysis from the Global Burden of Disease Study 2021. Lancet Haematol. 2023;10(8):e585\u201399. https:\/\/doi.org\/10.1016\/S2352-3026(23)00118-7.","journal-title":"Lancet Haematol"},{"issue":"6","key":"3077_CR10","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.blre.2013.09.001","volume":"27","author":"J Kanter","year":"2013","unstructured":"Kanter J, Kruse-Jarres R. Management of sickle cell disease from childhood through adulthood. Blood Rev. 2013;27(6):279\u201387. https:\/\/doi.org\/10.1016\/j.blre.2013.09.001.","journal-title":"Blood Rev"},{"key":"3077_CR11","unstructured":"Schnog JB, Duits AJ, Muskiet FAJ. Sickle cell disease; a general overview. 2004;62(10):364\u201374. PMID: 15683091."},{"key":"3077_CR12","unstructured":"Borhade MB, Patel P, Kondamudi NP. Sickle cell crisis. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2025. Available from: http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK526064\/."},{"issue":"1","key":"3077_CR13","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1186\/s13052-021-01109-1","volume":"47","author":"R Colombatti","year":"2021","unstructured":"Colombatti R, Casale M, Russo G. Disease burden and quality of life in children with sickle cell disease in Italy: time to be considered a priority. Ital J Pediatr. 2021;47(1):163. https:\/\/doi.org\/10.1186\/s13052-021-01109-1.","journal-title":"Ital J Pediatr"},{"key":"3077_CR14","unstructured":"Adolescent health. Available from: https:\/\/www.who.int\/health-topics\/adolescent-health."},{"issue":"13","key":"3077_CR15","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1016\/j.jacc.2011.10.900","volume":"59","author":"MT Gladwin","year":"2012","unstructured":"Gladwin MT, Sachdev V. Cardiovascular abnormalities in sickle cell disease. J Am Coll Cardiol. 2012;59(13):1123\u201333. https:\/\/doi.org\/10.1016\/j.jacc.2011.10.900.","journal-title":"J Am Coll Cardiol"},{"key":"3077_CR16","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71. https:\/\/doi.org\/10.1136\/bmj.n71.","journal-title":"BMJ"},{"issue":"1","key":"3077_CR17","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1186\/s13643-016-0384-4","volume":"5","author":"M Ouzzani","year":"2016","unstructured":"Ouzzani M, Hammady H, Fedorowicz Z, Elmagarmid A. Rayyan\u2014a web and mobile app for systematic reviews. Syst Rev. 2016;5(1):210. https:\/\/doi.org\/10.1186\/s13643-016-0384-4.","journal-title":"Syst Rev"},{"key":"3077_CR18","doi-asserted-by":"publisher","unstructured":"Moola S, Munn Z, Tufunaru C, Aromataris E, Sears K, Sfetc R, et al. Systematic reviews of Aetiology and risk. In: Aromataris E, Lockwood C, Porritt K, Pilla B, Jordan Z, editors. JBI Manual for Evidence Synthesis. JBI; 2024. Available from: https:\/\/synthesismanual.jbi.global. https:\/\/doi.org\/10.46658\/JBIMES-24-06.","DOI":"10.46658\/JBIMES-24-06"},{"issue":"2","key":"3077_CR19","doi-asserted-by":"publisher","first-page":"64","DOI":"10.35566\/jbds\/v3n2\/wang","volume":"3","author":"N Wang","year":"2023","unstructured":"Wang N. Conducting meta-analyses of proportions in R. J Behav Data Sci. 2023;3(2):64\u2013126. https:\/\/doi.org\/10.35566\/jbds\/v3n2\/wang.","journal-title":"J Behav Data Sci"},{"issue":"18","key":"3077_CR20","doi-asserted-by":"publisher","first-page":"2641","DOI":"10.1002\/sim.1221","volume":"21","author":"B Baujat","year":"2002","unstructured":"Baujat B, Mah\u00e9 C, Pignon JP, Hill C. A graphical method for exploring heterogeneity in meta-analyses: application to a meta-analysis of 65 trials. Stat Med. 2002;21(18):2641\u201352. https:\/\/doi.org\/10.1002\/sim.1221.","journal-title":"Stat Med"},{"issue":"4","key":"3077_CR21","doi-asserted-by":"publisher","first-page":"665","DOI":"10.4103\/NJM.NJM_97_20","volume":"29","author":"K Akaba","year":"2020","unstructured":"Akaba K, Nwogoh B, Obanife H, Essien O, Epoke E. Prevalence of chronic complications in adult sickle cell anemia patients in a tertiary hospital in South-South Nigeria. Niger J Med. 2020;29(4):665\u20139. https:\/\/doi.org\/10.4103\/NJM.NJM_97_20.","journal-title":"Niger J Med"},{"issue":"4","key":"3077_CR22","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1111\/bjh.15618","volume":"185","author":"RD Maggio","year":"2018","unstructured":"Maggio RD, Conrey A, Taylor TN, Lederman RJ, Rogers T, Nichols J, et al. Sickle related events following cardiac catheterisation: risk implication for other invasive procedures. Br J Haematol. 2018;185(4):778\u201380. https:\/\/doi.org\/10.1111\/bjh.15618.","journal-title":"Br J Haematol"},{"issue":"1","key":"3077_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/nrdp.2018.10","volume":"4","author":"GJ Kato","year":"2018","unstructured":"Kato GJ, Piel FB, Reid CD, Gaston MH, Ohene-Frempong K, Krishnamurti L, et al. Sickle cell disease. Nat Rev Dis Primers. 2018;4(1):1\u201322. https:\/\/doi.org\/10.1038\/nrdp.2018.10.","journal-title":"Nat Rev Dis Primers"},{"issue":"1","key":"3077_CR24","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1007\/s11239-021-02414-6","volume":"52","author":"OT Gbotosho","year":"2021","unstructured":"Gbotosho OT, Taylor M, Malik P. Cardiac pathophysiology in sickle cell disease. J Thromb Thrombolysis. 2021;52(1):248\u201359. https:\/\/doi.org\/10.1007\/s11239-021-02414-6.","journal-title":"J Thromb Thrombolysis"},{"issue":"1","key":"3077_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/medsci7010001","volume":"7","author":"C Antwi-Boasiako","year":"2018","unstructured":"Antwi-Boasiako C, Ahenkorah J, Donkor ES, Dzudzor B, Dankwah GB, Otu KH, et al. Correlation between soluble endothelial adhesion molecules and nitric oxide metabolites in sickle cell disease. Med Sci. 2018;7(1):1. https:\/\/doi.org\/10.3390\/medsci7010001.","journal-title":"Med Sci"},{"issue":"4","key":"3077_CR26","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1016\/j.ajpath.2018.12.012","volume":"189","author":"J Ansari","year":"2019","unstructured":"Ansari J, Gavins FNE. Ischemia-reperfusion injury in sickle cell disease. Am J Pathol. 2019;189(4):706\u201318. https:\/\/doi.org\/10.1016\/j.ajpath.2018.12.012.","journal-title":"Am J Pathol"},{"issue":"9","key":"3077_CR27","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1056\/NEJMoa035477","volume":"350","author":"M Gladwin","year":"2004","unstructured":"Gladwin M, Sachdev V, Jison M, Shizukuda Y, Plehn J, Minter K, et al. Pulmonary hypertension as a risk factor for death in patients with sickle cell disease. N Engl J Med. 2004;350(9):886\u201395. https:\/\/doi.org\/10.1056\/NEJMoa035477.","journal-title":"N Engl J Med"},{"issue":"9","key":"3077_CR28","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1016\/j.amjmed.2004.03.034","volume":"117","author":"KI Ataga","year":"2004","unstructured":"Ataga KI, Sood N, De Gent G, Kelly E, Henderson AG, Jones S, et al. Pulmonary hypertension in sickle cell disease. Am J Med. 2004;117(9):665\u20139. https:\/\/doi.org\/10.1016\/j.amjmed.2004.03.034.","journal-title":"Am J Med"},{"key":"3077_CR29","doi-asserted-by":"publisher","first-page":"e18743064292252","DOI":"10.2174\/0118743064292252240422100911","volume":"18","author":"YA Elfaki","year":"2024","unstructured":"Elfaki YA, Ibrahim AS, Merghani TH. Prevalence of pulmonary hypertension among Sudanese patients with sickle cell disease. Open Respir Med J. 2024;18:e18743064292252. https:\/\/doi.org\/10.2174\/0118743064292252240422100911.","journal-title":"Open Respir Med J"},{"issue":"7","key":"3077_CR30","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1002\/ajh.21187","volume":"83","author":"ES Klings","year":"2008","unstructured":"Klings ES, Anton Bland D, Rosenman D, Princeton S, Odhiambo A, Li G, et al. Pulmonary arterial hypertension and left-sided heart disease in sickle cell disease: clinical characteristics and association with soluble adhesion molecule expression. Am J Hematol. 2008;83(7):547\u201353. https:\/\/doi.org\/10.1002\/ajh.21187.","journal-title":"Am J Hematol"},{"key":"3077_CR31","doi-asserted-by":"publisher","unstructured":"Fonseca GHH, Souza R, Salemi VMC, Jardim CVP, Gual, ro SFM. Pulmonary hypertension diagnosed by right heart catheterisation in sickle cell disease. Eur Respir J. 2012;39(1):112\u20138. https:\/\/doi.org\/10.1183\/09031936.00134410.","DOI":"10.1183\/09031936.00134410"},{"issue":"4","key":"3077_CR32","doi-asserted-by":"publisher","first-page":"A5815","DOI":"10.1016\/j.chest.2024.06.3446","volume":"166","author":"D Ford","year":"2024","unstructured":"Ford D, Gilliard C. Prevalence of sickle cell disease-related pulmonary hypertension based on noninvasive vs invasive hemodynamic evaluation. Chest. 2024;166(4):A5815. https:\/\/doi.org\/10.1016\/j.chest.2024.06.3446.","journal-title":"Chest"},{"issue":"9","key":"3077_CR33","doi-asserted-by":"publisher","first-page":"4792","DOI":"10.3390\/ijms25094792","volume":"25","author":"S Chatzidavid","year":"2024","unstructured":"Chatzidavid S, Flevari P, Tombrou I, Anastasiadis G, Dimopoulou M. Pulmonary hypertension in sickle cell disease: novel findings of gene polymorphisms related to pathophysiology. Int J Mol Sci. 2024;25(9):4792. https:\/\/doi.org\/10.3390\/ijms25094792.","journal-title":"Int J Mol Sci"},{"issue":"4","key":"3077_CR34","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1111\/ejh.13140","volume":"101","author":"SM Badawy","year":"2018","unstructured":"Badawy SM, Payne AB, Rodeghier MJ, Liem RI. Exercise capacity and clinical outcomes in adults followed in the Cooperative Study of Sickle Cell Disease (CSSCD). Eur J Haematol. 2018;101(4):532\u201341. https:\/\/doi.org\/10.1111\/ejh.13140.","journal-title":"Eur J Haematol"},{"key":"3077_CR35","doi-asserted-by":"publisher","first-page":"440","DOI":"10.61336\/ejcm\/24-4-55","volume":"14","author":"SK Sahoo","year":"2024","unstructured":"Sahoo SK, Khatua B, Behera SK, Bhol DR, Satpathy P. Pulmonary arterial hypertension in children with sickle cell anaemia. Eur J Cardiovasc Med. 2024;14:440\u20133. https:\/\/doi.org\/10.61336\/ejcm\/24-4-55.","journal-title":"Eur J Cardiovasc Med"},{"issue":"9","key":"3077_CR36","doi-asserted-by":"publisher","first-page":"e0184287","DOI":"10.1371\/journal.pone.0184287","volume":"12","author":"OJ Sokunbi","year":"2017","unstructured":"Sokunbi OJ, Ekure EN, Temiye EO, Anyanwu R, Okoromah CAN. Pulmonary hypertension among 5 to 18 year old children with sickle cell anaemia in Nigeria. PLoS ONE. 2017;12(9):e0184287. https:\/\/doi.org\/10.1371\/journal.pone.0184287.","journal-title":"PLoS ONE"},{"issue":"1","key":"3077_CR37","doi-asserted-by":"publisher","first-page":"35","DOI":"10.36922\/itps.198","volume":"6","author":"VS Hariharan","year":"2023","unstructured":"Hariharan VS. Pulmonary hypertension among children and adolescents with sickle cell anemia: a systematic review and meta-analysis. INNOSC Theranostics Pharmacol Sci. 2023;6(1):35\u201345. https:\/\/doi.org\/10.36922\/itps.198.","journal-title":"INNOSC Theranostics Pharmacol Sci"},{"issue":"1","key":"3077_CR38","doi-asserted-by":"publisher","first-page":"e29980","DOI":"10.1002\/pbc.29980.","volume":"70","author":"KH Chan","year":"2023","unstructured":"Chan KH, Rizvi SH, De Jesus-Rojas W, Stark JM, Mosquera RA, Prada-Ruiz AC, et al. Pulmonary hypertension screening in children with sickle cell disease. Pediatr Blood Cancer. 2023;70(1):e29980. https:\/\/doi.org\/10.1002\/pbc.29980.","journal-title":"Pediatr Blood Cancer"},{"issue":"1","key":"3077_CR39","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s13643-024-02461-z","volume":"13","author":"N Khargekar","year":"2024","unstructured":"Khargekar N, Banerjee A, Athalye S, Mahajan N, Kargutkar N, Tapase P, et al. Role of hydroxyurea therapy in the prevention of organ damage in sickle cell disease: a systematic review and meta-analysis. Syst Rev. 2024;13(1):60. https:\/\/doi.org\/10.1186\/s13643-024-02461-z.","journal-title":"Syst Rev"},{"issue":"6","key":"3077_CR40","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1164\/rccm.201401-0065ST.","volume":"189","author":"ES Klings","year":"2014","unstructured":"Klings ES, Machado RF, Barst RJ, Morris CR, Mubarak KK, Gordeuk VR, et al. An official American Thoracic Society clinical practice guideline: diagnosis, risk stratification, and management of pulmonary hypertension of sickle cell disease. Am J Respir Crit Care Med. 2014;189(6):727\u201340. https:\/\/doi.org\/10.1164\/rccm.201401-0065ST.","journal-title":"Am J Respir Crit Care Med"},{"key":"3077_CR41","doi-asserted-by":"publisher","unstructured":"Oni OO, Odeyemi AO, Olasinde YT, Odeyemi AO, Olufemi-Aworinde KJ, Abolarin AT, Ala OA. Pulmonary Hypertension and Left Ventricular Geometric Types in Sickle Cell Anemia. Am J Cardiol. 2023;203:175\u201383. https:\/\/doi.org\/10.1016\/j.amjcard.2023.06.100.","DOI":"10.1016\/j.amjcard.2023.06.100"},{"key":"3077_CR42","doi-asserted-by":"publisher","unstructured":"Musa BM, Odoh CN, Galadanci NA, Saidu H, Aliyu MH. Lower than expected elevated tricuspid regurgitant jet velocity in adults with sickle cell disease in Nigeria. Int Health. 2018;10(5):356\u201362. https:\/\/doi.org\/10.1093\/inthealth\/ihx074.","DOI":"10.1093\/inthealth\/ihx074"},{"key":"3077_CR43","doi-asserted-by":"publisher","unstructured":"Mehari A, Igbineweka N, Allen D, Nichols J, Thein SL, Weir NA. Abnormal Ventilation-Perfusion Scan Is Associated with Pulmonary Hypertension in Sickle Cell Adults. J Nucl Med. 2019;60(1):86\u201392. https:\/\/doi.org\/10.2967\/jnumed.118.211466.","DOI":"10.2967\/jnumed.118.211466"},{"issue":"12","key":"3077_CR44","doi-asserted-by":"publisher","first-page":"030006052110553","DOI":"10.1177\/03000605211055385","volume":"49","author":"S Alkindi","year":"2021","unstructured":"Alkindi S, Al-Ghadani AR, Al-Zeheimi SR, Alkindi SY, Fawaz N, Ballas SK, et al. Predicting risk factors for thromboembolic complications in patients with sickle cell anaemia \u2013 lessons learned for prophylaxis. J Int Med Res. 2021;49(12):03000605211055385. https:\/\/doi.org\/10.1177\/03000605211055385.","journal-title":"J Int Med Res"},{"issue":"Supplement 1","key":"3077_CR45","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1182\/blood-2024-204271","volume":"144","author":"A Ajayi","year":"2024","unstructured":"Ajayi A, Zhang L, Agarwal S, Bhasin N. Venous thromboembolism in individuals with sickle cell disease- a retrospective review of this understudied problem. Blood. 2024;144(Supplement 1):1256. https:\/\/doi.org\/10.1182\/blood-2024-204271.","journal-title":"Blood"},{"issue":"2","key":"3077_CR46","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1111\/bjh.14655","volume":"178","author":"A Brunson","year":"2017","unstructured":"Brunson A, Lei A, Rosenberg AS, White RH, Keegan T, Wun T. Increased incidence of VTE in sickle cell disease patients: risk factors, recurrence and impact on mortality. Br J Haematol. 2017;178(2):319\u201326. https:\/\/doi.org\/10.1111\/bjh.14655.","journal-title":"Br J Haematol"},{"issue":"Supplement_1","key":"3077_CR47","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1182\/blood-2019-122199","volume":"134","author":"RC Lawrence","year":"2019","unstructured":"Lawrence RC, Khan SL, Gupta V, Scarpato B, Strykowski R, Newman J, et al. Patients with sickle cell disease and venous thromboembolism experience increased frequency of vasoocclusive events. Blood. 2019;134(Supplement_1):999. https:\/\/doi.org\/10.1182\/blood-2019-122199.","journal-title":"Blood"},{"issue":"12","key":"3077_CR48","doi-asserted-by":"publisher","first-page":"2010","DOI":"10.1111\/jth.12744","volume":"12","author":"RP Naik","year":"2014","unstructured":"Naik RP, Streiff MB, Haywood C, Segal JB, Lanzkron S. Venous thromboembolism incidence in the Cooperative Study of Sickle Cell Disease. J Thromb Haemost. 2014;12(12):2010\u20136. https:\/\/doi.org\/10.1111\/jth.12744.","journal-title":"J Thromb Haemost"},{"issue":"20","key":"3077_CR49","doi-asserted-by":"publisher","first-page":"6498","DOI":"10.3390\/jcm12206498","volume":"12","author":"MS Ziyadah","year":"2023","unstructured":"Ziyadah MS, Mansory EM, Alahwal HM, Bahashwan SM, Almohammadi AT, Radhwi OO, et al. Predisposing factors and incidence of venous thromboembolism among hospitalized patients with sickle cell disease. J Clin Med. 2023;12(20):6498. https:\/\/doi.org\/10.3390\/jcm12206498.","journal-title":"J Clin Med"},{"issue":"4","key":"3077_CR50","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1111\/ejh.13811","volume":"109","author":"HC Okoye","year":"2022","unstructured":"Okoye HC, Ezekekwu C, Nwagha TU, Korubo K, Omunakwe HE, Nnachi OC, et al. Prevalence of venous thromboembolism and its associations in a large racially homogenous population of sickle cell disease patients. Eur J Haematol. 2022;109(4):321\u20136. https:\/\/doi.org\/10.1111\/ejh.13811.","journal-title":"Eur J Haematol"},{"issue":"4","key":"3077_CR51","doi-asserted-by":"publisher","first-page":"102471","DOI":"10.1016\/j.rpth.2024.102471","volume":"8","author":"J Light","year":"2024","unstructured":"Light J, Abrams CM, Ilich A, Huang S, Zhu H, Baskin-Miller J, et al. Disease severity drives risk of venous thrombotic events in women with sickle cell disease in a single-center retrospective study. Res Pract Thromb Haemost. 2024;8(4):102471. https:\/\/doi.org\/10.1016\/j.rpth.2024.102471.","journal-title":"Res Pract Thromb Haemost"},{"issue":"1","key":"3077_CR52","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1182\/asheducation-2017.1.423","volume":"2017","author":"MT Gladwin","year":"2017","unstructured":"Gladwin MT. Cardiovascular complications in patients with sickle cell disease. Hematology. 2017;2017(1):423\u201330. https:\/\/doi.org\/10.1182\/asheducation-2017.1.423.","journal-title":"Hematology"},{"issue":"3","key":"3077_CR53","doi-asserted-by":"publisher","first-page":"20","DOI":"10.5315\/wjh.v9.i3.20","volume":"9","author":"JS Lopes","year":"2022","unstructured":"Lopes JS, Viana \u00cdG, Santos MLC, Melo FF, Oliveira MV, Souza CL. Cardiopulmonary changes in patients with sickle cell anemia: a systematic review. World J Hematol. 2022;9(3):20\u20139. https:\/\/doi.org\/10.5315\/wjh.v9.i3.20.","journal-title":"World J Hematol"},{"issue":"2","key":"3077_CR54","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1046\/j.1365-2141.2003.04594.x","volume":"123","author":"EA Manci","year":"2003","unstructured":"Manci EA, Culberson DE, Yang YM, Gardner TM, Powell R, Haynes J, et al. Causes of death in sickle cell disease: an autopsy study. Br J Haematol. 2003;123(2):359\u201365. https:\/\/doi.org\/10.1046\/j.1365-2141.2003.04594.x.","journal-title":"Br J Haematol"},{"issue":"14","key":"3077_CR55","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1093\/eurheartj\/ehv555","volume":"37","author":"T Damy","year":"2016","unstructured":"Damy T, Bodez D, Habibi A, Guellich A, Rappeneau S, Inamo J, et al. Haematological determinants of cardiac involvement in adults with sickle cell disease. Eur Heart J. 2016;37(14):1158\u201367. https:\/\/doi.org\/10.1093\/eurheartj\/ehv555.","journal-title":"Eur Heart J"},{"issue":"Supplement_1","key":"3077_CR56","doi-asserted-by":"publisher","first-page":"ehac779.111","DOI":"10.1093\/eurheartj\/ehac779.111","volume":"44","author":"N Natarajan","year":"2023","unstructured":"Natarajan N, Al-Mohammad AA, Robinson GR, Pillai RP, Tsitsikas DT, Ang RA. Prevalence of cardiovascular disease in Sickle cell disease (SCD)- an echocardiographic and pharmacological analysis. Eur Heart J. 2023;44(Supplement_1):ehac779.111. https:\/\/doi.org\/10.1093\/eurheartj\/ehac779.111.","journal-title":"Eur Heart J"},{"key":"3077_CR57","doi-asserted-by":"publisher","unstructured":"Gharaibeh A, Zmaili M, Alamer M, El HAH, Najdawi H, Volk M, et al. Ekg findings in sickle cell disease patients. J Am Coll Cardiol. 2024;83(13_Supplement):123\u2013123. https:\/\/doi.org\/10.1016\/S0735-1097(24)02113-2.","DOI":"10.1016\/S0735-1097(24)02113-2"},{"key":"3077_CR58","doi-asserted-by":"publisher","first-page":"207","DOI":"10.2147\/JBM.S455564","volume":"15","author":"S Bahashwan","year":"2024","unstructured":"Bahashwan S, Almuhanna RM, Al Hazza MT, Baarma RW, AlNajjar AY, Siddiqui FS, et al. Cardiovascular consequences of sickle cell disease. J Blood Med. 2024;15:207\u201316. https:\/\/doi.org\/10.2147\/JBM.S455564.","journal-title":"J Blood Med"},{"issue":"157","key":"3077_CR59","doi-asserted-by":"publisher","first-page":"200054","DOI":"10.1183\/16000617.0054-2020","volume":"29","author":"M Arigliani","year":"2020","unstructured":"Arigliani M, Gupta A. Management of chronic respiratory complications in children and adolescents with sickle cell disease. Eur Respir Rev. 2020;29(157):200054. https:\/\/doi.org\/10.1183\/16000617.0054-2020.","journal-title":"Eur Respir Rev"},{"issue":"1","key":"3077_CR60","doi-asserted-by":"publisher","first-page":"38","DOI":"10.4103\/ijmh.IJMH_13_21","volume":"27","author":"AO Ugwu","year":"2022","unstructured":"Ugwu AO. Gender differences in the complications of sickle cell anemia. Int J Med Health Dev. 2022;27(1):38\u201342. https:\/\/doi.org\/10.4103\/ijmh.IJMH_13_21.","journal-title":"Int J Med Health Dev"},{"key":"3077_CR61","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1182\/blood-2020-140896","volume":"136","author":"RV Masese","year":"2020","unstructured":"Masese RV, Bulgin D, Knisely M, Preiss L, Stevenson E, Hankins JS, et al. Sex based differences in sickle cell disease. Blood. 2020;136:37. https:\/\/doi.org\/10.1182\/blood-2020-140896.","journal-title":"Blood"},{"issue":"2","key":"3077_CR62","doi-asserted-by":"publisher","first-page":"e0318751","DOI":"10.1371\/journal.pone.0318751","volume":"20","author":"M Ghazaiean","year":"2025","unstructured":"Ghazaiean M, Darvishi-Khezri H, Najafi B, Karami H, Kosaryan M. Global prevalence of elevated estimated pulmonary artery systolic pressure in clinically stable children and adults with sickle cell disease: a systematic review and meta-analysis. PLoS ONE. 2025;20(2):e0318751. https:\/\/doi.org\/10.1371\/journal.pone.0318751.","journal-title":"PLoS ONE"},{"issue":"9","key":"3077_CR63","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.3324\/haematol.2014.120030","volume":"100","author":"S Tewari","year":"2015","unstructured":"Tewari S, Brousse V, Piel FB, Menzel S, Rees DC. Environmental determinants of severity in sickle cell disease. Haematologica. 2015;100(9):1108\u201316. https:\/\/doi.org\/10.3324\/haematol.2014.120030.","journal-title":"Haematologica"},{"issue":"6","key":"3077_CR64","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1016\/j.hoc.2022.07.014","volume":"36","author":"AA Desai","year":"2022","unstructured":"Desai AA, Machado RF, Cohen RT. The cardiopulmonary complications of sickle cell disease. Hematol Oncol Clin North Am. 2022;36(6):1217\u201337. https:\/\/doi.org\/10.1016\/j.hoc.2022.07.014.","journal-title":"Hematol Oncol Clin North Am"},{"issue":"1","key":"3077_CR65","doi-asserted-by":"publisher","first-page":"33","DOI":"10.25259\/JPATS_30_2023","volume":"5","author":"SK Owusu","year":"2024","unstructured":"Owusu SK, Mapani MK, Visagie A, Marozva N, Yassin A, Vanker A, et al. Pulmonary function assessments and clinical correlates in children with sickle cell disease in Cape Town, South Africa. J Pan Afr Thorac Soc. 2024;5(1):33\u201344. https:\/\/doi.org\/10.25259\/JPATS_30_2023.","journal-title":"J Pan Afr Thorac Soc"},{"issue":"12","key":"3077_CR66","doi-asserted-by":"publisher","first-page":"2515","DOI":"10.1007\/s00247-023-05750-2","volume":"53","author":"R Wagdy","year":"2023","unstructured":"Wagdy R, Fathy A, Elnekidy A, Salaheldin G, Nazir H, Fahmy R, et al. Evaluation of cardiac fibrosis and subclinical cardiac changes in children with sickle cell disease using magnetic resonance imaging, echocardiography, and serum galectin-3. Pediatr Radiol. 2023;53(12):2515\u201327. https:\/\/doi.org\/10.1007\/s00247-023-05750-2.","journal-title":"Pediatr Radiol"},{"key":"3077_CR67","doi-asserted-by":"publisher","unstructured":"Alan S, Mendez-Marti SR, Zik C, Ershler WB. Advancing through challenges: current strategies in sickle cell disease management. Ann Blood. 2024;9(0). Available from: https:\/\/aob.amegroups.org\/article\/view\/9770. https:\/\/doi.org\/10.21037\/aob-24-14.","DOI":"10.21037\/aob-24-14"},{"issue":"23","key":"3077_CR68","doi-asserted-by":"publisher","first-page":"3867","DOI":"10.1182\/bloodadvances.2019000916","volume":"3","author":"RI Liem","year":"2019","unstructured":"Liem RI, Lanzkron S, D. Coates T, DeCastro L, Desai AA, Ataga KI, et al. American Society of Hematology 2019 guidelines for sickle cell disease: cardiopulmonary and kidney disease. Blood Adv. 2019;3(23):3867\u201397. https:\/\/doi.org\/10.1182\/bloodadvances.2019000916.","journal-title":"Blood Adv"},{"issue":"1","key":"3077_CR69","doi-asserted-by":"publisher","first-page":"76","DOI":"10.5334\/aogh.4132","volume":"89","author":"L Hegemann","year":"2023","unstructured":"Hegemann L, Narasimhan V, Marfo K, Kuma-Aboagye P, Ofori-Acquah S, Odame I. Bridging the access gap for comprehensive sickle cell disease management across Sub-Saharan Africa: learnings for other global health interventions? Ann Glob Health. 2023;89(1):76. https:\/\/doi.org\/10.5334\/aogh.4132.","journal-title":"Ann Glob Health"},{"issue":"4","key":"3077_CR70","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1080\/17474086.2022.2063116","volume":"15","author":"M Dua","year":"2022","unstructured":"Dua M, Bello-Manga H, Carroll YM, Galadanci AA, Ibrahim UA, King AA, et al. Strategies to increase access to basic sickle cell disease care in low- and middle-income countries. Expert Rev Hematol. 2022;15(4):333\u201344. https:\/\/doi.org\/10.1080\/17474086.2022.2063116.","journal-title":"Expert Rev Hematol"},{"issue":"8","key":"3077_CR71","doi-asserted-by":"publisher","first-page":"e633","DOI":"10.1016\/S2352-3026(23)00096-0","volume":"10","author":"FB Piel","year":"2023","unstructured":"Piel FB, Rees DC, DeBaun MR, Nnodu O, Ranque B, Thompson AA, et al. Defining global strategies to improve outcomes in sickle cell disease: a Lancet Haematology Commission. Lancet Haematol. 2023;10(8):e633\u201386. https:\/\/doi.org\/10.1016\/S2352-3026(23)00096-0.","journal-title":"Lancet Haematol"},{"issue":"12","key":"3077_CR72","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1097\/01.mph.0000194022.17968.bf","volume":"27","author":"MN Suell","year":"2005","unstructured":"Suell MN, Bezold LI, Okcu MF, Mahoney DH, Shardonofsky F, Mueller BU. Increased pulmonary artery pressures among adolescents with sickle cell disease. J Pediatr Hematol Oncol. 2005;27(12):654\u20138. https:\/\/doi.org\/10.1097\/01.mph.0000194022.17968.bf.","journal-title":"J Pediatr Hematol Oncol"}],"container-title":["Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13643-026-03077-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13643-026-03077-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13643-026-03077-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T13:01:16Z","timestamp":1774530076000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13643-026-03077-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,11]]},"references-count":72,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3077"],"URL":"https:\/\/doi.org\/10.1186\/s13643-026-03077-1","relation":{},"ISSN":["2046-4053"],"issn-type":[{"value":"2046-4053","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,11]]},"assertion":[{"value":"10 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"100"}}